<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>BMC Systems Biology - Most viewed articles</title>
		<link>http://www.biomedcentral.com/bmcsystbiol/mostviewed/</link>
		<description>Most viewed articles in last 30 days from BMC Systems Biology (ISSN 1752-0509) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
         <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/80"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/79"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/74"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/77"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/82"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/83"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/81"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/84"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/75"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/73"/>			    
            
            </rdf:Seq>
        </items>
    </channel>
    
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/80">
            
            <title>The use of Gene Ontology terms for predicting highly-connected 'hub' nodes in protein-protein interaction networks</title>
			<description>Background:
Protein-protein interactions mediate a wide range of cellular functions and responses and have been studied rigorously through recent large-scale proteomics experiments and bioinformatics analyses. One of the most important findings of those endeavours was the observation that 'hub' proteins participate in significant numbers of protein interactions and play critical roles in the organization and function of cellular protein interaction networks (PINs) 12. It has also been demonstrated that such hub proteins may constitute an important pool of attractive drug targets.Thus, it is crucial to be able to identify hub proteins based not only on experimental data but also by means of bioinformatics predictions.
Results:
A hub protein classifier has been developed based on the available interaction data and Gene Ontology (GO) annotations for proteins in the Escherichia coli, Saccharomyces cerevisiae, Drosophila melanogaster and Homo sapiens genomes. In particular, by utilizing the machine learning method of boosting trees we were able to create a predictive bioinformatics tool for the identification of proteins that are likely to play the role of a hub in protein interaction networks. Testing the developed hub classifier on external sets of experimental protein interaction data in Methicillin-resistant Staphylococcus aureus (MRSA) 252 and Caenorhabditis elegans demonstrated that our approach can predict hub proteins with a high degree of accuracy.A practical application of the developed bioinformatics method has been illustrated by the effective protein bait selection for large-scale pull-down experiments that aim to map complete protein-protein interaction networks for several species.
Conclusion:
The successful development of an accurate hub classifier demonstrated that highly-connected proteins tend to share certain relevant functional properties reflected in their Gene Ontology annotations. It is anticipated that the developed bioinformatics hub classifier will represent a useful tool for the theoretical prediction of highly-interacting proteins, the study of cellular network organizations, and the identification of prospective drug targets &#8211; even in those organisms that currently lack large-scale protein interaction data.</description>
			<link>http://www.biomedcentral.com/1752-0509/2/80</link>		
			<dc:creator>Michael Hsing, Kendall Grant Byler and Artem Cherkasov</dc:creator>
			<dc:source>BMC Systems Biology 2008, 2:80</dc:source>
			<dc:subject>Number of accesses: 875</dc:subject>
			<dc:date>2008-09-16</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-80</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>80</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-16</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/79">
            
            <title>A genome-scale metabolic reconstruction of Pseudomonas putida KT2440: iJN746 as a cell factory.</title>
			<description>Background:
Pseudomonas putida is the best studied pollutant degradative bacteria and is harnessed by industrial biotechnology to synthesize fine chemicals. Since the publication of P. putida KT2440's genome, some in silico analyses of its metabolic and biotechnology capacities have been published. However, global understanding of the capabilities of P. putida KT2440 requires the construction of a metabolic model that enables the integration of classical experimental data along with genomic and high-throughput data. The constraint-based reconstruction and analysis (COBRA) approach has been successfully used to build and analyze in silico genome-scale metabolic reconstructions.
Results:
We present a genome-scale reconstruction of P. putida KT2440's metabolism, iJN746, which was constructed based on genomic, biochemical, and physiological information. This manually-curated reconstruction accounts for 746 genes, 950 reactions, and 911 metabolites. iJN746 captures biotechnologically relevant pathways, including polyhydroxyalkanoate synthesis and catabolic pathways of aromatic compounds (e.g., toluene, benzoate, phenylacetate, nicotinate), not described in other metabolic reconstructions or biochemical databases. The predictive potential of iJN746 was validated using experimental data including growth performance and gene deletion studies. Furthermore, in silico growth on toluene was found to be oxygen-limited, suggesting the existence of oxygen-efficient pathways not yet annotated in P. putida's genome. Moreover, we evaluated the production efficiency of polyhydroxyalkanoates from various carbon sources and found fatty acids as the most prominent candidates, as expected. 
Conclusion:
Here we presented the first genome-scale reconstruction of P. putida, a biotechnologically interesting all-surrounder. Taken together, this work illustrates the utility of iJN746 as i) a knowledge-base, ii) a discovery tool, and iii) an engineering platform to explore P. putida's potential in bioremediation and bioplastic production.</description>
			<link>http://www.biomedcentral.com/1752-0509/2/79</link>		
			<dc:creator>Juan Nogales, Bernhard O. Palsson and Ines Thiele</dc:creator>
			<dc:source>BMC Systems Biology 2008, 2:79</dc:source>
			<dc:subject>Number of accesses: 848</dc:subject>
			<dc:date>2008-09-16</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-79</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>79</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-16</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/74">
            
            <title>A review of imaging techniques for systems biology</title>
			<description>This paper presents a review of imaging techniques and of their utility in system biology. During the last decade systems biology has matured into a distinct field and imaging has been increasingly used to enable the interplay of experimental and theoretical biology. In this review, we describe and compare the roles of microscopy, ultrasound, CT (Computed Tomography), MRI (Magnetic Resonance Imaging), PET (Positron Emission Tomography), and molecular probes such as quantum dots and nanoshells in systems biology. As a unified application area among these different imaging techniques, examples in cancer targeting are highlighted.</description>
			<link>http://www.biomedcentral.com/1752-0509/2/74</link>		
			<dc:creator>Armen R Kherlopian, Ting Song, Qi Duan, Mathew A Neimark, Ming J Po, John K Gohagan and Andrew F Laine</dc:creator>
			<dc:source>BMC Systems Biology 2008, 2:74</dc:source>
			<dc:subject>Number of accesses: 713</dc:subject>
			<dc:date>2008-08-12</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-74</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>74</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-12</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/77">
            
            <title>A compartment model of VEGF distribution in blood, healthy and diseased tissues</title>
			<description>Background:
Angiogenesis is a process by which new capillaries are formed from pre-existing blood vessels in physiological (e.g., exercise, wound healing) or pathological (e.g., ischemic limb as in peripheral arterial disease, cancer) contexts. This neovascular mechanism is mediated by the vascular endothelial growth factor (VEGF) family of cytokines. Although VEGF is often targeted in anti-angiogenic therapies, there is little knowledge about how its concentration may vary between tissues and the vascular system. A compartment model is constructed to study the VEGF distribution in the tissue (including matrix-bound, cell surface receptor-bound and free VEGF isoforms) and in the blood. We analyze the sensitivity of this distribution to the secretion rate, clearance rate and vascular permeability of VEGF.
Results:
We find that, in a physiological context, VEGF concentration varies approximately linearly with the VEGF secretion rate. VEGF concentration in blood but not in tissue is dependent on the vascular permeability of healthy tissue. Model simulations suggest that relative VEGF increases are similar in blood and tissue during exercise and return to baseline within several hours. In a pathological context (tumor), we find that blood VEGF concentration is relatively insensitive to increased vascular permeability in tumors, to the secretion rate of VEGF by tumors and to the clearance. However, it is sensitive to the vascular permeability in the healthy tissue. Finally, the VEGF distribution profile in healthy tissue reveals that about half of the VEGF is complexed with the receptor tyrosine kinase VEGFR2 and the co-receptor Neuropilin-1. In diseased tissues, this binding can be reduced to 15% while VEGF bound to the extracellular matrix and basement membranes increases.
Conclusion:
The results are of importance for physiological conditions (e.g., exercise) and pathological conditions (e.g., peripheral arterial disease, coronary artery disease, cancer). This mathematical model can serve as a tool for understanding the VEGF distribution in physiological and pathological contexts as well as a foundation to investigate pro- or anti-angiogenic strategies.</description>
			<link>http://www.biomedcentral.com/1752-0509/2/77</link>		
			<dc:creator>Marianne O Stefanini, Florence TH Wu, Feilim Mac Gabhann and Aleksander S Popel</dc:creator>
			<dc:source>BMC Systems Biology 2008, 2:77</dc:source>
			<dc:subject>Number of accesses: 477</dc:subject>
			<dc:date>2008-08-19</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-77</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>77</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-19</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/82">
            
            <title>Origin of structural difference in metabolic networks with respect to temperature</title>
			<description>Background:
Metabolism is believed to adaptively shape-shift with changing environment. In recent years, a structural difference with respect to temperature, which is an environmental factor, has been revealed in metabolic networks, implying that metabolic networks transit with temperature. Subsequently, elucidatation of the origin of these structural differences due to temperature is important for understanding the evolution of life. However, the origin has yet to be clarified due to the complexity of metabolic networks.
Results:
Consequently, we propose a simple model with a few parameters to explain the transitions. We first present mathematical solutions of this model using mean-field approximation, and demonstrate that this model can reproduce structural properties, such as heterogeneous connectivity and hierarchical modularity, in real metabolic networks both qualitatively and quantitatively. We next show that the model parameters correlate with optimal growth temperature. In addition, we present a relationship between multiple cyclic properties and optimal growth temperature in metabolic networks.
Conclusion:
From the proposed model, we find that such structural properties are determined by the emergence of a short-cut path, which reduces the minimum distance between two nodes on a graph. Furthermore, we investigate correlations between model parameters and growth temperature; as a result, we find that the emergence of the short-cut path tends to be inhibited with increasing temperature. In addition, we also find that the short-cut path bypasses a relatively long path at high temperature when the emergence of the new path is not inhibited. Even further, additional network analysis provides convincing evidence of the reliability of the proposed model and its conclusions on the possible origins of differences in metabolic network structure.</description>
			<link>http://www.biomedcentral.com/1752-0509/2/82</link>		
			<dc:creator>Kazuhiro Takemoto and Tatsuya Akutsu</dc:creator>
			<dc:source>BMC Systems Biology 2008, 2:82</dc:source>
			<dc:subject>Number of accesses: 467</dc:subject>
			<dc:date>2008-09-22</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-82</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>82</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-22</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/83">
            
            <title>Parameter estimation and determinability analysis applied to Drosophila gap gene circuits</title>
			<description>Background:
Mathematical modeling of real-life processes often requires the estimation of unknown parameters. Once the parameters are found by means of optimization, it is important to assess the quality of the parameter estimates, especially if parameter values are used to draw biological conclusions from the model.
Results:
In this paper we describe how the quality of parameter estimates can be analyzed. We apply our methodology to assess parameter determinability for gene circuit models of the gap gene network in early Drosophila embryos.
Conclusions:
Our analysis shows that none of the parameters of the considered model can be determined individually with reasonable accuracy due to correlations between parameters. Therefore, the model cannot be used as a tool to infer quantitative regulatory weights. On the other hand, our results show that it is still possible to draw reliable qualitative conclusions on the regulatory topology of the gene network. Moreover, it improves previous analyses of the same model by allowing us to identify those interactions for which qualitative conclusions are reliable, and those for which they are ambiguous.</description>
			<link>http://www.biomedcentral.com/1752-0509/2/83</link>		
			<dc:creator>Maksat Ashyraliyev, Johannes Jaeger and Joke G Blom</dc:creator>
			<dc:source>BMC Systems Biology 2008, 2:83</dc:source>
			<dc:subject>Number of accesses: 460</dc:subject>
			<dc:date>2008-09-25</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-83</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>83</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-25</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/81">
            
            <title>Employing conservation of co-expression to improve functional inference</title>
			<description>Background:
Observing co-expression between genes suggests that they are functionally coupled. Co-expression of orthologous gene pairs across species may improve function prediction beyond the level achieved in a single species.
Results:
We used orthology between genes of the three different species S. cerevisiae, D. melanogaster, and C. elegans to combine co-expression across two species at a time. This led to increased function prediction accuracy when we incorporated expression data from either of the other two species and even further increased when conservation across both of the two other species was considered at the same time. Employing the conservation across species to incorporate abundant model organism data for the prediction of protein interactions in poorly characterized species constitutes a very powerful annotation method.
Conclusion:
To be able to employ the most suitable co-expression distance measure for our analysis, we evaluated the ability of four popular gene co-expression distance measures to detect biologically relevant interactions between pairs of genes. For the expression datasets employed in our co-expression conservation analysis above, we used the GO and the KEGG PATHWAY databases as gold standards. While the differences between distance measures were small, Spearman correlation showed to give most robust results.</description>
			<link>http://www.biomedcentral.com/1752-0509/2/81</link>		
			<dc:creator>Carsten O Daub and Erik LL Sonnhammer</dc:creator>
			<dc:source>BMC Systems Biology 2008, 2:81</dc:source>
			<dc:subject>Number of accesses: 417</dc:subject>
			<dc:date>2008-09-22</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-81</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>81</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-22</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/84">
            
            <title>Network evaluation from the consistency of the graph structure with the measured data</title>
			<description>Background:
A knowledge-based network, which is constructed by extracting as many relationships identified by experimental studies as possible and then superimposing them, is one of the promising approaches to investigate the associations between biological molecules. However, the molecular relationships change dynamically, depending on the conditions in a living cell, which suggests implicitly that all of the relationships in the knowledge-based network do not always exist. Here, we propose a novel method to estimate the consistency of a given network with the measured data: i) the network is quantified into a log-likelihood from the measured data based on the Gaussian network, and ii) the probability of the likelihood corresponding to the measured data, named the graph consistency probability (GCP), is estimated based on the generalized extreme value distribution.
Results:
The plausibility and the performance of the present procedure are illustrated by various graphs with simulated data, and with two types of actual gene regulatory networks in Escherichia coli: the SOS DNA repair system with the corresponding data measured by fluorescence, and a set of 29 networks with data measured under anaerobic conditions by microarray. In the simulation study, the procedure for estimating GCP is illustrated by a simple network, and the robustness of the method is scrutinized in terms of various aspects: dimensions of sampling data, parameters in the simulation study, magnitudes of data noise, and variations of network structures. In the actual networks, the former example revealed that our method operates well for an actual network with a size similar to the simulated networks, and the latter example illustrated that our method can select the activated network candidates consistent with the actual data measured under specific conditions, among the many network candidates. 
Conclusions:
The present method shows the possibility of bridging between the static network from the literature and the corresponding measurement, and thus will shed light on the network structure variations that occur in response to the environments in a living cell. </description>
			<link>http://www.biomedcentral.com/1752-0509/2/84</link>		
			<dc:creator>Shigeru Saito, Sachiyo Aburatani and Katsuhisa Horimoto</dc:creator>
			<dc:source>BMC Systems Biology 2008, 2:84</dc:source>
			<dc:subject>Number of accesses: 413</dc:subject>
			<dc:date>2008-10-01</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-84</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>84</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-10-01</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/75">
            
            <title>Explaining oscillations and variability in the p53-Mdm2 system</title>
			<description>Background:
In individual living cells p53 has been found to be expressed in a series of discrete pulses after DNA damage. Its negative regulator Mdm2 also demonstrates oscillatory behaviour. Attempts have been made recently to explain this behaviour by mathematical models but these have not addressed explicit molecular mechanisms. We describe two stochastic mechanistic models of the p53/Mdm2 circuit and show that sustained oscillations result directly from the key biological features, without assuming complicated mathematical functions or requiring more than one feedback loop. Each model examines a different mechanism for providing a negative feedback loop which results in p53 activation after DNA damage. The first model (ARF model) looks at the mechanism of p14ARF which sequesters Mdm2 and leads to stabilisation of p53. The second model (ATM model) examines the mechanism of ATM activation which leads to phosphorylation of both p53 and Mdm2 and increased degradation of Mdm2, which again results in p53 stabilisation. The models can readily be modified as further information becomes available, and linked to other models of cellular ageing.
Results:
The ARF model is robust to changes in its parameters and predicts undamped oscillations after DNA damage so long as the signal persists. It also predicts that if there is a gradual accumulation of DNA damage, such as may occur in ageing, oscillations break out once a threshold level of damage is acquired. The ATM model requires an additional step for p53 synthesis for sustained oscillations to develop. The ATM model shows much more variability in the oscillatory behaviour and this variability is observed over a wide range of parameter values. This may account for the large variability seen in the experimental data which so far has examined ARF negative cells.
Conclusion:
The models predict more regular oscillations if ARF is present and suggest the need for further experiments in ARF positive cells to test these predictions. Our work illustrates the importance of systems biology approaches to understanding the complex role of p53 in both ageing and cancer.</description>
			<link>http://www.biomedcentral.com/1752-0509/2/75</link>		
			<dc:creator>Carole J Proctor and Douglas A Gray</dc:creator>
			<dc:source>BMC Systems Biology 2008, 2:75</dc:source>
			<dc:subject>Number of accesses: 387</dc:subject>
			<dc:date>2008-08-18</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-75</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>75</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-18</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/73">
            
            <title>On the origin of distribution patterns of motifs in biological networks</title>
			<description>Background:
Inventories of small subgraphs in biological networks have identified commonly-recurring patterns, called motifs. The inference that these motifs have been selected for function rests on the idea that their occurrences are significantly more frequent than random.
Results:
Our analysis of several large biological networks suggests, in contrast, that the frequencies of appearance of common subgraphs are similar in natural and corresponding random networks.
Conclusion:
Indeed, certain topological features of biological networks give rise naturally to the common appearance of the motifs. We therefore question whether frequencies of occurrences are reasonable evidence that the structures of motifs have been selected for their functional contribution to the operation of networks.</description>
			<link>http://www.biomedcentral.com/1752-0509/2/73</link>		
			<dc:creator>Arun S Konagurthu and Arthur M Lesk</dc:creator>
			<dc:source>BMC Systems Biology 2008, 2:73</dc:source>
			<dc:subject>Number of accesses: 365</dc:subject>
			<dc:date>2008-08-12</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-73</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>73</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-12</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
	<cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
